Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. C. Hofmeister
Histone Deacetylase Inhibitors Enhance the Therapeutic Potential of Reovirus in Multiple Myeloma
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Histone Deacetylase Inhibitors in Multiple Myeloma
Hematology Reports
Hematology
Therapeutic Strategies to Enhance the Anticancer Efficacy of Histone Deacetylase Inhibitors
Journal of Biomedicine and Biotechnology
New Insights Into the Treatment of Multiple Myeloma With Histone Deacetylase Inhibitors
Current Pharmaceutical Design
Drug Discovery
Pharmacology
Role of Histone Deacetylase Inhibitors in Relapsed Refractory Multiple Myeloma: A Focus on Vorinostat and Panobinostat
Pharmacotherapy
Pharmacology
Inhibitors of Histone-Deacetylase
Journal of Applied Biomedicine
Genetics
Molecular Biology
Pharmacology
Biochemistry
Biological Sciences
Toxicology
Medicine
Agricultural
Neuroscience
Pharmaceutics
Gene Expression-Based Prediction of Myeloma Cell Sensitivity to Histone Deacetylase Inhibitors
British Journal of Cancer
Cancer Research
Oncology
The Short-Term Effect of Histone Deacetylase�inhibitors, Chidamide and Valproic Acid, On�the�NF‑κB�pathway in Multiple Myeloma Cells
International Journal of Molecular Medicine
Medicine
Genetics
Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
Frontiers in Oncology
Cancer Research
Oncology
The Therapeutic Potential of Cell Cycle Targeting in Multiple Myeloma
Oncotarget
Oncology